Susan F. Slovin

Oct 31, 2023 | frontiersin.org | Susan F. Slovin |Mario Salazar-Páramo |Kelsey Barrell

IntroductionThe idiopathic inflammatory myopathies (IIM) constitute a diverse group of systemic autoimmune diseases, which include various subtypes such as immune-mediated necrotizing myopathy, sporadic inclusion body myositis, polymyositis (PM), dermatomyositis (DM) (1). The estimated prevalence of PM and DM ranges from 5 to 22 per 100,000 people, while the incidence rate among individuals at risk is approximately 1.2 to 19 million per year.

Aug 15, 2023 | brnw.ch | Susan F. Slovin |Karen Knudsen |Susan Halabi |Renee de Leeuw

CONTEXTKey ObjectiveIs the frontline combination of abiraterone acetate/prednisone and cabazitaxel (AAP + C) in comparison with AAP alone beneficial to patients with metastatic castration-resistant prostate cancer (mCRPC) who are naïve to chemotherapy or androgen receptor signaling inhibitors?

Aug 10, 2023 | jamanetwork.com | Andrea Necchi |Vita-Salute San Raffaele |Susan F. Slovin |Joshua J. Meeks

Immunotherapy in the Treatment of Localized Genitourinary Cancers Abstract Importance  A true revolution in the management of advanced genitourinary cancers has occurred with the discovery and adoption of immunotherapy (IO). The therapeutic benefits of IO were recently observed not to be solely confined to patients with disseminated disease but also in select patients with localized and locally advanced genitourinary neoplasms.

Jul 3, 2023 | pubmed.ncbi.nlm.nih.gov | Susan F. Slovin |Slovin SF

Save citation to file Format: Add to My Bibliography Your saved search Name of saved search: Search terms: Frequency: Which day? Which day? Report format: Send at most: Send even when there aren't any new results Optional text in email: Create a file for external citation management software